MedTrace Logo

Study of Myopia Prevention in Children With Low Concentration of Atropine

NCT00541177 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2007-10-10

No results posted yet for this study

Summary

The purpose of this study is to test the hypothesis that myopia can be prevented by using a low concentration of atropine eyedrops once a week.

Conditions

  • Myopia

Interventions

DRUG

atropine

0.25% atropine

DRUG

tropicamide

0.5% tropicamide

Sponsors & Collaborators

  • Min-Sheng General Hospital

    lead OTHER

Principal Investigators

  • Leon Chih-Kai Liang, MD MMS · Min-Sheng General Hospital; National Yang-Ming university, Taiwan

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
7 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-04-30
Completion
2008-03-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00541177 on ClinicalTrials.gov